HIV-1 drug resistance among people living with HIV receiving dolutegravir-based anti-retroviral regimens in Uganda: a national laboratory-based survey using remnant viral load samples, 2022.

Saved in:
Bibliographic Details
Title: HIV-1 drug resistance among people living with HIV receiving dolutegravir-based anti-retroviral regimens in Uganda: a national laboratory-based survey using remnant viral load samples, 2022.
Authors: Watera C; Department of General Virololgy, Uganda Virus Research Institute (UVRI), Entebbe, Uganda., Da Silva JF; Division of Global HIV & TB, U.S. Centers for Disease Control and Prevention, Atlanta, USA., Namayanja G; Division of Global HIV & TB, U.S. Centers for Disease Control and Prevention, Kampala, Uganda., Asio JN; Department of General Virololgy, Uganda Virus Research Institute (UVRI), Entebbe, Uganda., Ssemwanga D; Department of General Virololgy, Uganda Virus Research Institute (UVRI), Entebbe, Uganda.; Sequencing Platform, Medical Research Council (MRC)/UVRI & London School of Hygiene and Tropical Medicine (LSHTM) Uganda Research Unit, Entebbe, Uganda., Pals S; Division of Global HIV & TB, U.S. Centers for Disease Control and Prevention, Atlanta, USA., Nabukenya M; Central Public Health Laboratories, Ministry of Health, Kampala, Uganda., Raizes E; Division of Global HIV & TB, U.S. Centers for Disease Control and Prevention, Atlanta, USA., Nanyonjo M; Sequencing Platform, Medical Research Council (MRC)/UVRI & London School of Hygiene and Tropical Medicine (LSHTM) Uganda Research Unit, Entebbe, Uganda., Elur B; Division of Global HIV & TB, U.S. Centers for Disease Control and Prevention, Kampala, Uganda., Nazziwa E; Division of Global HIV & TB, U.S. Centers for Disease Control and Prevention, Kampala, Uganda., Sanyu G; Department of General Virololgy, Uganda Virus Research Institute (UVRI), Entebbe, Uganda., Ayitewala A; Central Public Health Laboratories, Ministry of Health, Kampala, Uganda., Ssali M; AIDS Control Program, Ministry of Health, Kampala, Uganda., Katureebe C; AIDS Control Program, Ministry of Health, Kampala, Uganda., Balidawa H; AIDS Control Program, Ministry of Health, Kampala, Uganda., Zheng DP; Division of Global HIV & TB, U.S. Centers for Disease Control and Prevention, Atlanta, USA., Zeh C; Division of Global HIV & TB, U.S. Centers for Disease Control and Prevention, Atlanta, USA., Hackett S; Division of Global HIV & TB, U.S. Centers for Disease Control and Prevention, Atlanta, USA., Mwangi C; Division of Global HIV & TB, U.S. Centers for Disease Control and Prevention, Kampala, Uganda., Naluguza M; Division of Global HIV & TB, U.S. Centers for Disease Control and Prevention, Kampala, Uganda., Ntale J; Division of Global HIV & TB, U.S. Centers for Disease Control and Prevention, Kampala, Uganda., Katongole Mbidde E; Department of General Virololgy, Uganda Virus Research Institute (UVRI), Entebbe, Uganda., Kaleebu P; Department of General Virololgy, Uganda Virus Research Institute (UVRI), Entebbe, Uganda.; Sequencing Platform, Medical Research Council (MRC)/UVRI & London School of Hygiene and Tropical Medicine (LSHTM) Uganda Research Unit, Entebbe, Uganda.
Source: The Journal of antimicrobial chemotherapy [J Antimicrob Chemother] 2025 Aug 01; Vol. 80 (8), pp. 2126-2134.
Publication Type: Journal Article
Journal Info: Publisher: Oxford University Press Country of Publication: England NLM ID: 7513617 Publication Model: Print Cited Medium: Internet ISSN: 1460-2091 (Electronic) Linking ISSN: 03057453 NLM ISO Abbreviation: J Antimicrob Chemother Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1460-2091
DOI:10.1093/jac/dkaf180